<DOC>
	<DOCNO>NCT00094913</DOCNO>
	<brief_summary>The purpose study identify early predictor memory brain deterioration pre-clinical Alzheimer 's disease use positron emission tomography ( PET ) monitor brain glucose metabolism .</brief_summary>
	<brief_title>PET Changes Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description>Previous study indicate brain 's glucose metabolism rate potentially may early indicator damage particular region brain cause AD , include loss neuron , synapsis , change . Many change report among patient mild cognitive impairment ( MCI ) , group know increase risk AD . The overall goal study use FDG-PET ( 2- [ ( 18 ) F ] fluoro-2-deoxy-d-glucose/positron-emission tomography ) determine whether metabolic abnormality hippocampus predict memory brain deterioration middle age , identify brain glucose metabolism predictor future MCI . Participants study group 3 main group 35 , include young individual ( 20-40 year age ) , 41-90 year-old normal , MCI individual without risk memory decline . Participants undergo baseline 36-month follow-up exam include comprehensive medical , neurologic , psychiatric evalutions ; lumbar puncture ; rest FDG-PET ; MRI scan ; neuropsychological battery . A brief medical exam , full neuropsychological battery , MRI scan administer 18 month . Two subgroup ( group 4 5 ) 15 create group 1 2 18 month participate evaluation memory performance acute hyperglycemia saline challenge effect hippocampal formation glucose metabolism .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Males female minimum high school education age 50 90 select Groups 1 2 . For Group 3 , normal subject age 20 49 year age select . The Groups 1 2 balanced age , three group balance gender ApoE genotype . Discontinuance psychotropic and/or cognitively active medication least four week prior evaluation . Past history MRI evidence brain damage include significant trauma , stroke , hydrocephalus , lacunar infarct , seizure , mental retardation serious neurological disorder . Significant history alcoholism drug abuse . Any history psychiatric illness ( e.g. , schizophrenia , mania depression ) . Any focal sign significant neuropathology . A score 4 great Modified Hachinski Ischemia Scale , indicative cerebrovascular disease . A total score 16 Hamilton Depression Scale exclude possible case primary depression . Evidence clinically relevant hypertensive , cardiac , pulmonary , vascular , metabolic hematologic condition . Specific exclusion make individual fast glucose level &gt; 110 mg/dl . Physical impairment severity adversely affect validity psychological testing . Hostility refusal cooperate . Any prosthetic device ( e.g. , pacemaker surgical clip ) could affect magnetic field employ MRI image . Evidence cognitive memory impairment reach early AD level initial evaluation . At baseline , delay paragraph recall zscores &gt; 2 reference group .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Aging</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Alzheimer disease , preclinical</keyword>
	<keyword>Hippocampal formation</keyword>
	<keyword>Glucose metabolism</keyword>
</DOC>